SecBot SecBot
SECBOTREPLAY Home › Report › KPTI

KPTI · Karyopharm Therapeutics filed for Chapter 11 bankruptcy and entered…

Karyopharm Therapeutics Inc. · 8-K filed Nov 2, 2026 at 09:21 ET

At the news

BEARISHIMPACT 7/10

8-K filed Nov 2, 2026 at 09:21 ET

Karyopharm Therapeutics filed for Chapter 11 bankruptcy and entered into a Restructuring Support Agreement with lenders and noteholders for a merger with Ayrmid Ltd. The company states existing equity holders will receive no distribution and expects a complete loss on their investment. The transaction is expected to close in Q1 2027.

  • Karyopharm filed voluntary Chapter 11 petitions in the Southern District of Texas on November 2, 2026.
  • The company entered into a Restructuring Support Agreement providing for a merger with Ayrmid Ltd.
  • Existing common stock and convertible preferred stock holders will receive no payment or distribution.
  • The company expects existing equity securities will have no value and holders will experience a complete loss.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access